These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6592940)

  • 21. Blood lipid profile in healthy subjects treated with ticlopidine.
    Violi F; Alessandri C; Iuliano L; Ghiselli A; Perrone A; Balsano F
    Atherosclerosis; 1985 Dec; 58(1-3):291-4. PubMed ID: 4091884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of ticlopidine and heparin on hemodialysis in dogs.
    Gross ML; Bush H; Weinger R; Hamburger RJ; Flamenbaum W
    J Lab Clin Med; 1982 Dec; 100(6):887-95. PubMed ID: 7142790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thrombotic etiology of stress ulcers. 1. The effect of anticoagulant and antiplatelet aggregators in the development of stress ulcers in rats.
    Kumashiro R; Pavlides CA; Kholoussy AM; Matsumoto T
    Am Surg; 1983 Aug; 49(8):417-22. PubMed ID: 6614663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Migraine or transient ischemic attacks in a patient with essential thrombocythaemia. Treatment with ticlopidine (author's transl)].
    Bousser MG; Conard J; Lecrubier C; Bousser J
    Ann Med Interne (Paris); 1980; 131(2):87-90. PubMed ID: 7396326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prasugrel (Effient) vs. clopidogrel (Plavix).
    Med Lett Drugs Ther; 2009 Sep; 51(1320):69-70. PubMed ID: 19738549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of ticlopidine and aspirin on endotoxin-induced disseminated intravascular coagulation in rats.
    Paris J
    Thromb Haemost; 1983 Dec; 50(4):894-5. PubMed ID: 6665770
    [No Abstract]   [Full Text] [Related]  

  • 27. Ticlopidine and adenylate cyclase.
    Bonne C; Battais E
    Agents Actions Suppl; 1984; 15():88-96. PubMed ID: 6592947
    [No Abstract]   [Full Text] [Related]  

  • 28. Toxicological studies of ticlopidine in laboratory animals.
    Mazué G; Berthe J; Combes M; Garbay TM; Gouy D; Lacheretz F; Remandet B; Vic P
    Agents Actions Suppl; 1984; 15():126-35. PubMed ID: 6592943
    [No Abstract]   [Full Text] [Related]  

  • 29. [Use of ticlopidine in chronic hemodialyzed patients. Counter-indication in future renal transplant receivers].
    Lang P; Plaisant B; Benoit G; Brasseur L; Charpentier B; Fries D
    Presse Med; 1985 Apr; 14(16):894-5. PubMed ID: 3158926
    [No Abstract]   [Full Text] [Related]  

  • 30. [Prodrug activation as a crucial difference. Prasugrel - a new ADP receptor antagonist].
    Alban S
    Pharm Unserer Zeit; 2009; 38(4):320-8. PubMed ID: 19572350
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of ticlopidine in the prevention of recurrences of cerebral ischemic accidents: comparative study with dipyridamol].
    Sancho Rieger J; López-Trigo Picho J
    Med Clin (Barc); 1984 Jan; 82(2):62-4. PubMed ID: 6608645
    [No Abstract]   [Full Text] [Related]  

  • 32. A platelet aggregation inhibitor--ticlopidine--in diabetic nephropathy: a randomized double blind study.
    Nyberg G; Larsson O; Westberg NG; Aurell M; Jagenburg R; Blohmé G
    Clin Nephrol; 1984 Mar; 21(3):184-7. PubMed ID: 6705280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Technological and biopharmaceutical aspects. Antiplatelet agents for oral administration].
    Breitkreutz J
    Pharm Unserer Zeit; 2009; 38(4):330-7. PubMed ID: 19572353
    [No Abstract]   [Full Text] [Related]  

  • 34. A possible method to control prolongations of bleeding time under antiplatelet therapy with ticlopidine.
    Thébault J; Blatrix C; Blanchard J; Panak E
    Thromb Haemost; 1982 Aug; 48(1):6-8. PubMed ID: 7135344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological studies on ticlopidine, a new platelet aggregation inhibitor. Part I: Cardiovascular effects.
    Akashi A; Tamura K; Hirohashi M; Watanabe K; Kasahara A
    Arzneimittelforschung; 1980; 30(3):409-14. PubMed ID: 7387750
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of 5-(2-chlorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine hydrochloride (Ticlopidine), a platelet aggregation inhibitor, on blood-borne metastasis.
    Kohga S; Kinjo M; Tanaka K; Ogawa H; Ishihara M; Tanaka N
    Cancer Res; 1981 Nov; 41(11 Pt 1):4710-4. PubMed ID: 7306988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pharmazie in unserer Zeit 4/2009].
    Alban S; Dingermann T
    Pharm Unserer Zeit; 2009; 38(4):295. PubMed ID: 19572344
    [No Abstract]   [Full Text] [Related]  

  • 38. The effects of cyclosporin A, ticlopidine hydrochloride and cobra venom factor on the hyperacute rejection of discordant renal xenografts.
    Green CJ; Kemp E; Kemp G
    Invest Cell Pathol; 1980; 3(4):415-6. PubMed ID: 7007299
    [No Abstract]   [Full Text] [Related]  

  • 39. [Ticlopidine in heart surgery with cardiopulmonary by-pass (author's transl)].
    Renner C; Guilmet D; Curtet JM
    Nouv Presse Med; 1980 Nov; 9(43):3249-51. PubMed ID: 7454568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prasugrel versus clopidogrel. From the American Heart Association meeting, 2007].
    Schaerlig E
    Rev Med Suisse; 2008 Feb; 4(144):434-5. PubMed ID: 18320775
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.